|
NCT01113606
|
|
A Trial of Skin Care Protocols for Facial Resurfacing
|
Phase 4
|
Completed
|
|
NCT02352987
|
2015-03-01 |
Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar Keratosis
|
Phase 2
|
Not Yet Recruiting
|
|
NCT02356159
|
2015-01-01 |
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
|
Phase 1/Phase 2
|
Recruiting
|
|
NCT02104817
|
2014-10-01 |
Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
|
Phase 3
|
Recruiting
|
|
NCT02249104
|
2014-08-01 |
Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump, Cetaphil® DermaControl™ Moisturizer SPF 30, and Cetaphil® DermaControl™ Foam Wash Regimen in Student Athletes With Mild to Moderate Acne Vulgaris
|
Phase 4
|
Completed
|
|
NCT02151630
|
2014-05-01 |
Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts
|
Phase 2/Phase 3
|
Recruiting
|
|
NCT02142049
|
2014-05-01 |
Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma
|
Phase 1/Phase 2
|
Recruiting
|
|
NCT02087163
|
2014-02-01 |
The Use of Clear Aligners With Movement Enhacement Techniques
|
Phase 4
|
Recruiting
|
|
NCT02052752
|
2014-02-01 |
A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions
|
Phase 4
|
Completed
|
|
NCT02132377
|
2014-01-01 |
Effect of Dietary Fat Cooking Blend on Energy Expenditure in Children (Melt Phase II)
|
Phase 2
|
Recruiting
|
|
NCT01914627
|
2013-08-01 |
Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis
|
Phase 2
|
Completed
|
|
NCT01613924
|
2013-07-01 |
Efficacy of Handheld Acne Heat Device
|
Phase 4
|
Suspended
|
|
NCT01826630
|
2013-07-01 |
A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema
|
Phase 2/Phase 3
|
Terminated
|
|
NCT02022527
|
2013-06-01 |
Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis
|
Phase 4
|
Recruiting
|
|
NCT01909713
|
2013-05-01 |
Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin.
|
Phase 4
|
Completed
|
|
NCT01914718
|
2013-02-01 |
Dose-adjusted EPOCH-R in MYC Positive DLBCL
|
Phase 2
|
Terminated
|
|
NCT01654107
|
2012-07-01 |
Persistence-Targeted Smoking Cessation
|
Phase 1
|
Completed
|
|
NCT01818908
|
2012-06-01 |
Trial of DA-EPOCH Regimen for NHL With HLH
|
Phase 2
|
Recruiting
|
|
NCT01489800
|
2011-11-01 |
The Impact of Early Feeding After Radical Cystectomy for Bladder Cancer
|
Phase 3
|
Enrolling By Invitation
|
|
NCT01712295
|
2011-11-01 |
17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts
|
Phase 4
|
Recruiting
|
|
NCT01139749
|
2011-10-01 |
Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea
|
Phase 4
|
Recruiting
|
|
NCT01444911
|
2011-08-01 |
Evaluation of The Vaginal Renewal™ Program in Gynecologic Cancer Patients Experiencing Sexual Dysfunction
|
Phase 2
|
Terminated
|
|
NCT01446237
|
2011-06-01 |
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
|
Phase 4
|
Completed
|
|
NCT01897428
|
2011-04-01 |
PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg
|
Phase 1
|
Completed
|
|
NCT01763151
|
2010-09-01 |
Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism
|
Phase 4
|
Completed
|
|
NCT01250925
|
2010-08-01 |
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
|
Phase 4
|
Active, Not Recruiting
|
|
NCT01092182
|
2010-02-01 |
Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
|
Phase 2
|
Recruiting
|
|
NCT01059110
|
2010-02-01 |
Comparison of Five Treatments in Patients With Plantar Warts
|
Phase 4
|
Active, Not Recruiting
|
|
NCT00937105
|
2009-11-01 |
Daily Wear Corneal Infiltrative Event Study
|
Phase 4
|
Completed
|
|
NCT01030900
|
2009-10-01 |
Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas
|
Phase 2
|
Recruiting
|
|
NCT01706250
|
2009-09-01 |
U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™
|
Phase 4
|
Completed
|
|
NCT00983944
|
2009-09-01 |
Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma
|
Phase 2
|
Withdrawn
|
|
NCT00973804
|
2009-08-01 |
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
|
Phase 1
|
Terminated
|
|
NCT01706263
|
2009-08-01 |
U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne
|
Phase 4
|
Completed
|
|
NCT01409616
|
2009-04-01 |
To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their Effects
|
Phase 1
|
Completed
|
|
NCT00907335
|
2009-02-01 |
A Study of Acne Treatment in Children Ages 9 to 11
|
Phase 2
|
Completed
|
|
NCT00809341
|
2009-01-01 |
R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
|
Phase 2
|
Active, Not Recruiting
|
|
NCT01445535
|
2009-01-01 |
Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas
|
Phase 1
|
Active, Not Recruiting
|
|
NCT01293734
|
2008-12-01 |
Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute Episode of Bronchial Asthma.
|
Phase 2
|
Completed
|
|
NCT01080196
|
2008-04-01 |
Reducing Falls With RENEW in Older Adults Who Have Fallen
|
Phase 2
|
Recruiting
|
|
NCT00677794
|
2008-03-01 |
Small Bowel Cleansing Prior to Video Capsule Endoscopy Examination
|
Phase 4
|
Active, Not Recruiting
|
|
NCT00799136
|
2008-02-01 |
A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL
|
Phase 2
|
Completed
|
|
NCT01353352
|
2008-01-01 |
Evaluation of the Nursing C-Spine (Phase IV)
|
Phase 4
|
Completed
|
|
NCT00616239
|
2008-01-01 |
Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women
|
Phase 4
|
Completed
|
|
NCT01424332
|
2007-12-01 |
To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects
|
Phase 1
|
Completed
|
|
NCT00425074
|
2007-01-01 |
Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.
|
Phase 1
|
Completed
|
|
NCT00913185
|
2006-12-01 |
Comparison Study of Topical Acne Regimens
|
Phase 4
|
Completed
|
|
NCT00650117
|
2006-10-01 |
Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System
|
Phase 1
|
Completed
|
|
NCT01228656
|
2006-09-01 |
Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate
|
Phase 2
|
Suspended
|
|
NCT01229085
|
2006-09-01 |
Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis
|
Phase 3
|
Completed
|
|
NCT00305526
|
2006-04-01 |
REBEAT Resynchronisation and Beta-Blocker European Trial
|
Phase 4
|
Terminated
|
|
NCT00114738
|
2005-06-01 |
EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma
|
Phase 2
|
Recruiting
|
|
NCT00361322
|
2005-04-01 |
Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris
|
Phase 1/Phase 2
|
Completed
|
|
NCT00501254
|
2005-02-01 |
Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period
|
Phase 2/Phase 3
|
Completed
|
|
NCT00146848
|
2004-12-01 |
PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy
|
Phase 4
|
Completed
|
|
NCT00180323
|
2004-11-01 |
ACC - Atrial Contribution to CRT
|
Phase 4
|
Completed
|
|
NCT00180531
|
2004-02-01 |
Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2
|
Phase 4
|
Completed
|
|
NCT00158977
|
2003-11-01 |
CONTAK RENEWAL 3 AVT
|
Phase 3
|
Completed
|
|
NCT00158951
|
2003-03-01 |
Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF
|
Phase 2/Phase 3
|
Completed
|
|
NCT00060385
|
2003-03-01 |
Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma
|
Phase 2/Phase 3
|
Terminated
|
|
NCT00211497
|
2003-01-01 |
Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne
|
Phase 2
|
Completed
|
|
NCT00180375
|
2002-05-01 |
OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator
|
Phase 4
|
Completed
|
|
NCT00053768
|
2002-04-01 |
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
|
Phase 3
|
Active, Not Recruiting
|
|
NCT00211523
|
2000-10-01 |
Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne
|
Phase 2
|
Completed
|
|
NCT00006436
|
2000-10-01 |
EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection
|
Phase 2
|
Recruiting
|
|
NCT00005780
|
2000-06-01 |
Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00005964
|
2000-05-01 |
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
|
Phase 2
|
Completed
|
|
NCT02273505
|
2000-04-01 |
Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects
|
Phase 1
|
Completed
|
|
NCT00258128
|
2000-01-01 |
Effect of Salicylate on Glucose Metabolism in Insulin Resistance States
|
Phase 2/Phase 3
|
Completed
|
|
NCT00006669
|
1999-09-01 |
Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00004245
|
1999-08-01 |
Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
|
Phase 1
|
Completed
|
|
NCT00001563
|
1996-12-01 |
EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma
|
Phase 2
|
Completed
|
|
NCT00001430
|
1995-02-01 |
A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas
|
Phase 2
|
Completed
|
|
NCT00001379
|
1994-02-01 |
Treatment and Natural History Study of Lymphomatoid Granulomatosis
|
Phase 2
|
Recruiting
|
|
NCT00001337
|
1993-04-01 |
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
|
Phase 2
|
Recruiting
|